May & Baker of Nigeria plc, the nation’s second-biggest pharmaceutical maker by market value, started the year with a loss after tax of N47.12 million, as the company continues to grapple with rising production costs. For the year first three months, the company posted a loss after tax of N47
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp